78 related articles for article (PubMed ID: 23672054)
1. [Pharmacokinetic effect of Sappan Lignum on hydroxysafflor yellow A in Carthami Flos].
Xia L; Chen XM; Peng LR; Wang SX; Wang XW; Zuo Y; Zhang P; Liu QS; Zheng XH
Zhongguo Zhong Yao Za Zhi; 2013 Jan; 38(2):269-72. PubMed ID: 23672054
[TBL] [Abstract][Full Text] [Related]
2. Comparative Analysis of the Effects of Hydroxysafflor Yellow A and Anhydrosafflor Yellow B in Safflower Series of Herb Pairs Using Prep-HPLC and a Selective Knock-Out Approach.
Qu C; Wang LY; Jin WT; Tang YP; Jin Y; Shi XQ; Shang LL; Shang EX; Duan JA
Molecules; 2016 Nov; 21(11):. PubMed ID: 27827969
[TBL] [Abstract][Full Text] [Related]
3. Rapid screening and identification of anticoagulation component from carthami flos by two-dimensional thrombin affinity chromatography combined with HPLC-MS/MS.
Qiao Y; Shi Y; Wu C; Hou X; Pan X; Deng Z; Wang S
J Sep Sci; 2021 Aug; 44(16):3061-3069. PubMed ID: 34110096
[TBL] [Abstract][Full Text] [Related]
4. A novel oral preparation of hydroxysafflor yellow A base on a chitosan complex: a strategy to enhance the oral bioavailability.
Ma GN; Yu FL; Wang S; Li ZP; Xie XY; Mei XG
AAPS PharmSciTech; 2015 Jun; 16(3):675-82. PubMed ID: 25511808
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic Study on Protocatechuic Aldehyde and Hydroxysafflor Yellow A of Danhong Injection in Rats with Hyperlipidemia.
Zhou J; Li M; Jin W; Li X; Fan H; Zhang Y
Pharmacology; 2018; 102(3-4):154-160. PubMed ID: 30045035
[TBL] [Abstract][Full Text] [Related]
6. UFLC-Q-TOF/MS based screening and identification of the metabolites in plasma, bile, urine and feces of normal and blood stasis rats after oral administration of hydroxysafflor yellow A.
Jin Y; Wu L; Tang Y; Cao Y; Li S; Shen J; Yue S; Qu C; Shan C; Cui X; Zhang L; Duan JA
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Feb; 1012-1013():124-9. PubMed ID: 26827279
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic profiles of hydroxysafflor yellow A following intravenous administration of its pure preparations in healthy Chinese volunteers.
Li CY; Yin JG; Zhang J; Wang XX; Xu MJ; Liu F; Zou JD; Ju WZ
J Ethnopharmacol; 2015 Mar; 162():225-30. PubMed ID: 25576896
[TBL] [Abstract][Full Text] [Related]
8. Hydroxysafflor yellow A exerts antioxidant effects in a rat model of traumatic brain injury.
Wang Y; Zhang C; Peng W; Xia Z; Gan P; Huang W; Shi Y; Fan R
Mol Med Rep; 2016 Oct; 14(4):3690-6. PubMed ID: 27599591
[TBL] [Abstract][Full Text] [Related]
9. [Research progress in chemical constituents and pigment extraction process of Carthami Flos].
Zhang XM; Xiao JH; Wang Y; Tang YP; Yue SJ
Zhongguo Zhong Yao Za Zhi; 2024 Apr; 49(7):1725-1740. PubMed ID: 38812185
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of Active Ingredients of Salvia miltiorrhiza and Carthamus tinctorius in Compatibility in Normal and Cerebral Ischemia Rats: A Comparative Study.
Jin Y; Yu L; Xu F; Zhou J; Xiong B; Tang Y; Li X; Liu L; Jin W
Eur J Drug Metab Pharmacokinet; 2020 Apr; 45(2):273-284. PubMed ID: 31828667
[TBL] [Abstract][Full Text] [Related]
11. Solid lipid nanoparticles as carriers for oral delivery of hydroxysafflor yellow A.
Zhao B; Gu S; Du Y; Shen M; Liu X; Shen Y
Int J Pharm; 2018 Jan; 535(1-2):164-171. PubMed ID: 29107614
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous Optimization of the Ultrasonic Extraction Method and Determination of the Antioxidant Activities of Hydroxysafflor Yellow A and Anhydrosafflor Yellow B from Safflower Using a Response Surface Methodology.
Zhang Y; Yu L; Jin W; Li C; Wang Y; Wan H; Yang J
Molecules; 2020 Mar; 25(5):. PubMed ID: 32182800
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic-pharmacodynamic modeling analysis for hydroxysafflor yellow A-calycosin in compatibility in normal and cerebral ischemic rats: A comparative study.
Chen Q; Wan J; Zhang Y; He Y; Bao Y; Yu L; Yang J
Biomed Pharmacother; 2022 Jun; 150():112950. PubMed ID: 35427818
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic Comparison of Seven Major Bio-Active Components in Normal and Blood Stasis Rats after Oral Administration of Herb Pair Danggui-Honghua by UPLC-TQ/MS.
Jin Y; Tang YP; Zhu ZH; Shang EX; Pang HQ; Shi XQ; Chen YY; Wang J; Chang X; Kang A; Zhou GS; Shi YJ; Sun J; Tang ZS; Li SP; Duan JA
Molecules; 2017 Oct; 22(10):. PubMed ID: 29039793
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic characteristics of hydroxysafflor yellow A in normal and diabetic cardiomyopathy mice.
Yao R; Cao Y; Jiang R; Zhang X; Li F; Wang S
Biomed Chromatogr; 2021 Oct; 35(10):e5173. PubMed ID: 33982286
[TBL] [Abstract][Full Text] [Related]
16. Hydroxysafflor Yellow A Alleviates Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Mice.
Zhang Y; Song L; Pan R; Gao J; Zang BX; Jin M
Biol Pharm Bull; 2017; 40(2):135-144. PubMed ID: 28154251
[TBL] [Abstract][Full Text] [Related]
17. Hydroxysafflor yellows alleviate thrombosis and acetaminophen-induced toxicity in vivo by enhancing blood circulation and poison excretion.
Wang LW; Cui XY; He JF; Duan S; Liu CR; Shan CB; Wang Y; Ma CM
Phytomedicine; 2021 Jul; 87():153579. PubMed ID: 33991865
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive in vitro and in vivo metabolism study of hydroxysafflor yellow A.
Wu L; Tang Y; Shan C; Chai C; Zhou Z; Shi X; Ding N; Wang J; Lin L; Tan R
J Mass Spectrom; 2018 Feb; 53(2):99-108. PubMed ID: 29076598
[TBL] [Abstract][Full Text] [Related]
19. Screening of blood-activating active components from Danshen-Honghua herbal pair by spectrum-effect relationship analysis.
Wang YL; Zhang Q; Yin SJ; Cai L; Yang YX; Liu WJ; Hu YJ; Chen H; Yang FQ
Phytomedicine; 2019 Feb; 54():149-158. PubMed ID: 30668364
[TBL] [Abstract][Full Text] [Related]
20. [Establishment of concentration process and physical property parameter model of Carthami Flos extract based on quality by design].
Li-Li D; Cheng C; Yong-Jie W; Hua-Xiang W; Xin-Yu Z; Yu-Juan L; Zi-You G; Qing WU
Zhongguo Zhong Yao Za Zhi; 2020 Oct; 45(19):4633-4642. PubMed ID: 33164427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
